Active Pharmaceutical Ingredients - Dr Reddy's
Active Pharmaceutical Ingredients - Dr Reddy's

About Abiraterone Acetate API

Product
  • Therapeutic Category Oncology

  • CAS Number

    154229-18-2

  • API Technology

    Steroids

  • Dose Form

    Oral Solid/Tablets

  • Dr Reddy's Development Status

    Available

  • Available Regulatory Filing

    USDMF, Brazil DMF, EUDMF, Korea DMF, Russia DMF

Mecanismo de Ação

Abiraterone is an orally active inhibitor of the steroidal enzyme CYP17A1 (17 alpha-hydroxylase/C17,20 lyase). It inhibits CYP17A1 in a selective and irreversible manner via covalent binding mechanism.

Indicação

ZYTIGA is a CYP17 inhibitor indicated in combination with prednisone for the treatment of patients with

  • Metastatic castration-resistant prostate cancer (CRPC).
  • Metastatic high-risk castration-sensitive prostate cancer (CSPC)

Especialização do Dr. Reddy

Com sede em Hyderabad, Índia, o Dr. Reddy's Laboratories é um dos principais fornecedores de Ingredientes Farmacêuticos Ativos (API) do mundo. O negócio de API do Dr. Reddy é um parceiro preferencial para empresas farmacêuticas nos EUA, Europa, Brasil, América Latina, Japão, China, Coréia e mercados emergentes.

Os negócios de API do Dr. Reddy prosperam com os profundos pontos fortes técnicos estabelecidos nos últimos 30 anos no desenvolvimento e fabricação de APIs complexas, como esteróides, peptídeos, moléculas complexas de cadeia longa e APIs altamente potentes (HPAPIs / medicamentos para oncologia). Essa experiência é complementada por nossa capacidade em propriedade intelectual e assuntos regulatórios, o que nos ajuda a cumprir e exceder consistentemente os padrões regulatórios. A API do Dr. Reddy Abiraterona Acetato é o resultado de uma extensa experiência em pesquisa e desenvolvimento, PI e regulamentação.

Um componente essencial para ajudar nossos clientes a serem os primeiros no mercado é uma cadeia de suprimentos responsiva. Conseguimos isso garantindo que todas as nossas instalações estejam operando com eficiência e com os mais recentes padrões de qualidade, segurança e produtividade. Uma forte interconexão entre negócios e fábricas permite uma reação rápida às mudanças dinâmicas do mercado, para que possamos evitar escassez e atender a súbitas oscilações na demanda.

 

Get access to reliable and cost-effective abiraterone acetate API from Dr. Reddy's. As a leading manufacturer, we prioritize quality and affordability. To know more about Abiraterone Acetate price please contact us at [email protected]

Request for Quotation

Get in touch with us by filling out the form below. Our team will reach out to you shortly!

Phone
Country *
Select Product *
Select Regulatory Requirements
Select Purpose

Related APIs

Ácido Zoledrônico

Oncology

arrow

Dasatinibe

Oncology

arrow

Adagrasib

Oncology

arrow

Cloridrato De Bendamustina

Oncology

arrow

Fruquintinib

Oncology

arrow

Venetoclax

Oncology

arrow

Tucatinib

Oncology

arrow

Ripretinib

Oncology

arrow

Abiraterona Acetato

Oncology

arrow

Azacitidina

Oncology

arrow

Bortezomibe

Oncology

arrow

Cabazitaxel

Oncology

arrow

Cabozantinib HCl

Oncology

arrow

Cabozantinib S-Malate

Oncology

arrow

Capecitabina

Oncology

arrow

Carfilzomib

Oncology

arrow

Decitabina

Oncology

arrow

Deucravacitinib

Oncology

arrow

Apalutamide (Amorphous & Form B)

Oncology

arrow

Mesilato De Eribulina

Oncology

arrow

Gemcitabine Hydrochloride

Oncology

arrow

Lomustina

Oncology

arrow

Cloridrato De Nilotinibe

Oncology

arrow

Olaparib (Form A)

Oncology

arrow

Palbociclibe

Oncology

arrow

Pazopanib

Oncology

arrow

Dissódio Pemetrexede (hepta-hidratado)

Oncology

arrow

Pirtobrutinib

Oncology

arrow

Relugolix

Oncology

arrow

Pomalidomida

Oncology

arrow

Acalabrutinib

Oncology

arrow

Capivasertib

Oncology

arrow

Lenalidomida

Oncology

arrow

Midostaurin

Oncology

arrow

Lenvatinib Mesylate (Form C & MIBK Solvate)

Oncology

arrow

Enzalutamida

Oncology

arrow

FAQs

What drug class is ABIRATERONE ACETATE API?
  • It belongs to Anti-neoplastic drug class

What is ABIRATERONE ACETATE API used to treat?
  • It is a oncology product used to treat Metastatic castration-resistant prostate cancer (CRPC). Metastatic high-risk castration-sensitive prostate cancer (CSPC)

What are the dosage strengths available for ABIRATERONE ACETATE API ?
  • Abiraterone is available in 250 mg and 500 mg dosage forms

What are offerings of Dr. Reddy's for ABIRATERONE ACETATE API?
  • We offer polymorph Form-A for Abiraterone API

What is the process available for ordering ABIRATERONE ACETATE API?

Aviso legal

No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.

Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act (Bolar Exemption) and not for commercial sale.